Pyrogens refer to those substances which cause fever after administration of injection. Rise in the temperature of human body as well as body ache are some of the major reactions caused owing to the injection of harmful pyrogens in the body. Pyrogen testing helps in determination of the presence of endotoxin substances present in the human body. The pyrogen testing market can be segmented on the basis of application, test type, end-user and regions. The rising support especially from governments of various economies in order to launch new and more innovative drug options to fight with several new types of diseases has bolstered the overall demand for pyrogen testing products in the recent past. In addition to this, pyrogens are widely known as a major cause to body ache and fever after being injected into the human body. This testing of pyrogens helps in easy identification of the presence of endotoxin substances and is being widely used especially in the development of improved and new drugs across the globe.
Increasing growth of global pyrogen testing market is primarily anticipated to be the result of increasing number of biotechnology and pharmaceutical companies across the globe. In addition, increasing investments in research and development activities as well as rising approvals for new and improved drugs is another major factor bolstering the growth of pyrogen testing market, globally. Also, other factors such as increasing prevalence of chronic diseases, rising healthcare expenditure and favorable government support programs and initiatives are further augmenting the growth of global pyrogen testing market over the forecast period. However, factors such as high barrier for new market entrants is one of the key aspects anticipated to hamper the growth of pyrogen testing market over the forecast period. On the other hand, increasing medical tourism, especially in developing regions such as Latin America and Asia-Pacific, coupled with a rapidly growing healthcare industry in emerging economies such as India, China, Japan, Indonesia, Argentina, and Brazil among others are considered to be the future landscape for global pyrogen testing market over the forecast period. Moreover, increasing discovery of new and more innovative drugs along with huge investments in overall sunk costs, especially by biotechnological and pharmaceutical companies, coupled with rising support by the governments of various economies across the globe in healthcare sector are some other elements fueling the growth of pyrogen testing market.
The global pyrogen testing market can be segmented on the basis of application, product type and geography. On the basis of application, the global pyrogen testing market can be segmented into pharmaceuticals and biotechnology, medical devices manufacturing and others. By product type, the global pyrogen testing market can be segmented into kits & reagents, services and instruments. On the basis of region, the global pyrogen testing market can be segmented into North America, Latin America, Europe, Middle East & Africa (MEA) and Asia-Pacific. The demand in Asia-Pacific is analyzed to be the major driving factor for the growth of the pyrogen testing market. China is analyzed to lead the demand for pyrogen testing due to increased industrial production in the past half decade. The markets in emerging economies such as Brazil and India are also projected to grow rapidly.
Key players involved in the global pyrogen testing market are focusing on key market strategies such as acquisitions and mergers with local as well as established players. Moreover, companies are also focusing on collaborating with local players to increase their reach across all geographies and earn huge profits. Partnership with multinational companies to strengthen their market reach and goodwill is also anticipated to be a major market strategy in the global pyrogen testing market. Some of the major players involved in the manufacture and supply of pyrogen testing include Hyglos GmbH, Associates of Cape Cod Inc, GenScript, Wako Chemicals USA Inc., Charles River Laboratories International Inc.,Ellab A/S, Merck & Co Inc., Lonza Group, Sigma-Aldrich Corporation, and Thermo Fisher Scientific Inc.
Market by Product
· Kits & reagents
Market by Application
· Pharmaceuticals and biotechnology
· Medical devices manufacturing
Market by Geography
· North America
o Rest of Europe
o Rest of Asia-Pacific
· Latin America
o Rest of Latin America
· Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o Rest of MEA
Introduction The global epigenetics market size is anticipated to around USD 23.7 billion by 2026, this market is anticipated to grow with 20.5% CAGR during the forecast time period. Also, surge in need for better health related solution and diagnostic service drive the global epigenetic market during the coming years. Market Dynamics Diagnostic organizations are coming up new products, fo
Introduction The global women’s health diagnostics market size is anticipated to hit around USD 77.2 billion by 2026, this market is anticipated to grow with 7.3% CAGR during the forecast time period. Increasing occurrence of infectious diseases, for instance, urinary tract infection and hepatitis, among women is expected to boost the women’s health dia
Introduction The global Medical equipment rental market size is expected to reach a value of USD 65.4 billion by 2026, this market is anticipated to grow with 4.5% CAGR during the forecast time period. Growing base of geriatric and handicapped populace combined with rising requirement for home medicinal services items is pushing the market. Also, growing base of ge
Introduction The global Healthcare information systems market size is estimated to reach around USD 170.2 billion by 2026, this market is anticipated to grow with 7.8% CAGR during the forecast time period. Increase in technology penetration in healthcare sector drives the need for the healthcare information system market.
Introduction The global beauty and personal care products market size is estimated to reach around USD 717.6 billion by 2026, this market is anticipated to grow with 7.2% CAGR during the forecast time period. Market Dynamics Rising adoption and execution of AR in the magnific
Introduction The global medical device outsourcing market size in terms of revenue is expected to reach USD 193.6 billion in 2026. The global medical device outsourcing market is expected to experience a CAGR of 10.7% during the forecast period. Growing demand for medical devices tied with growing trend of off-shoring is expected to drive the market during the fore